Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Conexeu Sciences Inc. - Common Stock
(NQ:
CNXU
)
4.435
-0.565 (-11.30%)
Streaming Delayed Price
Updated: 12:27 PM EDT, Sep 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Conexeu Sciences Inc. - Common Stock
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
August 18, 2026
From
Equity Insider
Via
GlobeNewswire
The Biggest Winners Don't Compete in a Category. They Rewrite It. One Company Is Betting It Can Too.
August 18, 2026
Issued on behalf of Conexeu Sciences Inc.
From
American News Group
Via
GlobeNewswire
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
August 12, 2026
News Provided by USA News Group on behalf of Conexeu Sciences Inc.
From
USA News Group
Via
GlobeNewswire
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
August 11, 2026
News Provided by Biotech Insider on behalf of Conexeu Sciences Inc.
From
Biotech Insider
Via
GlobeNewswire
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
August 04, 2026
Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)
From
American News Group
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 15, 2026
Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday's regular session. The market value of their outstanding shares is at $24.9 million. Conexeu Sciences...
Via
Benzinga
A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next
July 15, 2026
From
Energy Metal News
Via
GlobeNewswire
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
July 01, 2026
From
Biotech Insider
Via
GlobeNewswire
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
June 25, 2026
From
Biotech Insider
Via
GlobeNewswire
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
June 18, 2026
From
Biotech Insider
Via
GlobeNewswire
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
June 16, 2026
From
World Street Intelligence
Via
GlobeNewswire
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
June 09, 2026
Issued on behalf of Conexeu Sciences Inc.
From
Equity Insider
Via
GlobeNewswire
Before the IPO: 4 Companies That Rewarded Investors Who Got In Early
↗
June 04, 2026
Weiss Ratings analyst Chris Graebe outlines how Regulation A offerings let retail investors access private companies like FJET, NUCL, and CNXU before their public listings.
Via
MarketBeat
Topics
Initial Public Offering
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
May 27, 2026
Issued on behalf of Conexeu Sciences Inc.
From
Biotech Insider
Via
GlobeNewswire
The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
May 22, 2026
From
Energy Metal News
Via
GlobeNewswire
A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching
May 22, 2026
Issued on behalf of Conexeu Sciences Inc.
From
World Street Intelligence
Via
GlobeNewswire
Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"
May 21, 2026
Reno, Nevada--(Newsfile Corp. - May 21, 2026) - Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company"), a biotechnology company advancing tissue...
Via
Newsfile
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
